A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Clinical trial NCT04521023 · COMPLETED
Trial details
- NCT number
- NCT04521023
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2020-01-28
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.